This is a great interview with our CEO, Liz Dallimore.
"To develop a neuroprotective therapy for stroke is the Holy Grail of biotech."
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.020(6.35%) |
Mkt cap ! $43.03M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 33.5¢ | 31.5¢ | $52.99K | 162.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 18127 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 53686 | 5 |
View Market Depth
| Last trade - 12.34pm 16/09/2025 (20 minute delay) ? |
| AGN (ASX) Chart |